3rd Annual TRDRP Smoking Cessation Day-Virtual 3/5/21

Wednesday, February 17, 2021

3rd Annual TRDRP Smoking Cessation Day-Virtual 3/5/21

Tobacco-Related Disease Research Program (TRDRP)

Fri, March 5, 2021


8:00 AM – 12:30 PM PST



Event Information


Interactive virtual seminar providing information, resources and tools to help providers successfully work on smoking cessation efforts

About this Event


  • Describe nationwide efforts and resources for implementing evidence-based tobacco treatment into clinical care
  • Understand the current status of California's law about flavored tobacco products and potential population impact
  • Cite biological and epidemiological evidence and health promotion strategies for smoking and COVID
  • Develop a plan for implementing evidence-based tobacco treatment in various clinical settings


7:15 - 8:00 am - Zoom Opens

8:00 - 8:30 am - Welcome & Summary - TRDRP Efforts for Smoking Cessation 3 Research Projects. Explanation of CME and CE Processes Theodore C. Friedman, MD, PhD - CDU, Norma Mtume, MHS, MA MFT, Friends ResearchInstitute, Joseph R. Guydish, PhD - UCSF, Elisa Tong, MD - UCD

8:30 – 9:15am -Smoking Cessation as the Fourth Pillar of Cancer Care: Lessons from the NCI's Moonshot Cancer Center Cessation Initiative (C3I) Program Michael C. Fiore, MD, MPH Director of the Center for Tobacco Research and Intervention, Professor of Medicine, University of Wisconsin

9:15 – 9:20 am - Break

9:20 -10:20 am - California’s Law to Restrict the Sale of Flavored Tobacco Products: The Tobacco Industry Referendum and Impact on Community Health (Panel)

  1. California's Law and the Tobacco Industry Referendum - Jim Knox, American Cancer Society Cancer Action Network
  2. Menthol and the African American Community - Valerie Yerger, MA, ND, UCSF
  3. Vaping and Youth/Young Adults - Bonnie Halpern-Felsher, PhD Stanford University

10:20- 10:25 am - Break

10:25 - 11:25 am - Quit for COVID: Why and How (Panel)

  1. How Smoking Worsens COVID-19 Infection in the Airways – Brigitte Gomperts, MD (UCLA)
  2. Smoking Associated with COVID-19 Progression – Stan Glantz, PhD, retired UCSF
  3. 'Quit for COVID' with the California Smokers' Helpline – Elisa Tong, MD, UCD

11:25- 11:30 am - Break

11:30 –12:30 pm - Helping Others to Quit (Breakout Session)

  1. Trainings for Clinics and Behavioral Health Staff in Your County – Cathy McDonald, MD - Alameda County ATOD Tobacco Dependence Treatment Training Program
  2. Smoking Cessation Pharmacotherapy – Brian Hurley, MD, MBA, DFASM – Friends Research Institute and Los Angeles County Department of Health Services
  3. Group Behavioral Therapy for Smoking Cessation – Tasha Dixon, LMFT – Friends

Sponsored by Tobacco-Related Disease Research Program, National Cancer Institute, L.A. County Health Agency, UC Davis Health, UC San Diego School of Medicine, UCLA Integrated Substance Abuse Program, California Smokers Helpline, Charles Drew University of Medicine and Science, UCSF, and Friends Research Institute

Credits Available:

Continuing Medical Education (CME) Accreditation

The University of California San Diego School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education, and cultural linguistic competency.

It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity, and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.

Continuing Education Credits (CEs)/ Contact Hours (CEHs)

The training course meets the qualifications for the provision of four (4.0) continuing education credits/ contact hours (CEs/CEHs). UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for four (4.0) hours of continuing education credit for LMFTs, LCSWs, LPCCS, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCsCASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1121), CATCs (ACCBC/CAADE, #CP40 872 C 0822), and CAODCs (CADTP, #151). CE credit will be awarded six-eight weeks after the virtual training. Partial credit will not be available for those participants who arrive late or leave early. Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program: Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing (UCLA ISAP, 11075 Santa Monica Boulevard, Suite 200, Los Angeles, CA 90025) or by phone (310- 267-5397).